Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
  1. 4 Planned sale Director sold 2,645 shares at $30.01 ($79,376)
  2. 4 Planned sale Chief Medical Officer sold 45,000 shares at an average $25.06 ($1,127,500)
  3. 4 Grant or award Chief Customer & Strat Officer acquired 19,800 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale CEO, Managing Director sold 14,581 shares at $9.06 ($132,104)
  6. 4 Open-market sale Chief Medical Officer sold 808 shares at $9.06 ($7,320)
  7. 4 Open-market sale Chief Legal Officer sold 3,412 shares at $9.06 ($30,913)
  8. 4 Open-market sale Chief Financial Officer sold 12,000 shares at $9.06 ($108,720)
  9. 4 Open-market sale CEO, Managing Director sold 34,437 shares at $9.95 ($342,648)
  10. 4 Open-market sale Chief Financial Officer sold 12,532 shares at $9.95 ($124,693)
  11. 4 Open-market sale Chief Legal Officer sold 8,578 shares at $9.95 ($85,351)
  12. 4 Open-market sale Chief Medical Officer sold 1,660 shares at $9.95 ($16,517)
  13. 4 Open-market sale CEO, Managing Director sold 12,378 shares at $23.86 ($295,339)
  14. 4 Open-market sale Chief Financial Officer sold 6,217 shares at $23.86 ($148,338)
  15. 4 Planned sale Director sold 25,613 shares at an average $24.62 ($630,483)
  16. 4 Planned sale Director sold 6,390 shares at $27.28 ($174,319)
  17. 4 Planned sale Director sold 31,434 shares at an average $27.26 ($856,881)
  18. 4 Planned sale Director sold 38,810 shares at an average $30.34 ($1,177,517)
  19. 4 Planned sale CEO, Managing Director sold 226,316 shares at an average $41.46 ($9,382,473)
  20. 4 Planned sale Chief Financial Officer sold 18,000 shares at an average $52.51 ($945,120)

Page 2 of 22 · 433 filings